Active ingredientClemastine FumarateCat. No. P-C186-001CAS 14976-57-9Family · Pharmaceutical analytical standards
Clemastine
A first-generation sedating H1 antihistamine, patented in 1960 and in clinical use since 1967: it relieves hay fever, itching and hives. This family brings together the active ingredient, pharmacopoeial impurities and other impurities.
Did you know?An old allergy medicine with a second life: at the University of California, San Francisco, it has been studied as a possible aid to repairing myelin in multiple sclerosis.
Go to the active ingredient →Active ingredientClemastine FumarateCat. No. P-C186-001CAS 14976-57-9
Pharmacopoeial impurityClemastine EP Impurity A (Mixture of Diastereomers)Cat. No. P-C186-002CAS 108825-05-4
Pharmacopoeial impurityClemastine EP Impurity A Fumarate (Mixture of Diastereomers)Cat. No. P-C186-003
Pharmacopoeial impurityClemastine EP Impurity BCat. No. P-C186-004CAS 1352549-49-5
Pharmacopoeial impurityClemastine EP Impurity DCat. No. P-C186-005CAS 67004-64-2
Pharmacopoeial impurityClemastine Fumarate EP Impurity CCat. No. P-C186-006CAS 59767-24-7
Pharmacopoeial impurityrac-Clemastine Fumarate EP Impurity B HClCat. No. P-C186-007
ImpurityClemastine Impurity 1Cat. No. P-C186-008CAS 20763-27-3
ImpurityClemastine Impurity 2 (R,S-isomer)Cat. No. P-C186-009CAS 61826-30-0
ImpurityClemastine Impurity 3 (S,S-isomer)Cat. No. P-C186-010CAS 61826-29-7
ImpurityClemastine Impurity 4 (S,R-isomer)Cat. No. P-C186-011CAS 61826-32-2No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceClemastine fumarate CRSEDQM code C2223000Family ClemastineNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.